Announcements Trials

Browse Landscape

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

OTHER 118 FED 3 OTHER_GOV 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

Paclitaxel 489 Carboplatin 435 Gemcitabine 393 Docetaxel 385 Cisplatin 358 pembrolizumab 341 Bevacizumab 334 Nivolumab 261 Pemetrexed 242 Capecitabine 221 Dexamethasone 212 Fluorouracil 211 Rituximab 203 Trastuzumab 193 Cyclophosphamide 190 Oxaliplatin 160 Erlotinib Hydrochloride 147 atezolizumab 145 Ipilimumab 145 Prednisone 144 Cetuximab 142 Irinotecan 139 Leucovorin 130 Doxorubicin 130 Sorafenib 120 Lenalidomide 117 Bortezomib 117 Sunitinib 107 Everolimus 93 130-nm albumin-bound paclitaxel 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × Methods × Clear all

NCT04528407 2025-02-13

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

BlueSky Immunotherapies GmbH

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡